Related Experiment Video
Updated: Jun 18, 2025

07:39
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
54
Flow cytometry-based diagnostic approach for inborn errors of immunity: experience from Algeria
Azzeddine Tahiat1, Reda Belbouab2, Abdelghani Yagoubi3
1Department of Medical Biology, Rouiba Hospital, University of Algiers 1, Algiers, Algeria.
Frontiers in Immunology
|July 29, 2024
Summary
Flow cytometry (FCM) is a valuable tool for diagnosing inborn errors of immunity (IEIs), especially in resource-limited settings. Our study shows FCM aids in diagnosing and categorizing diverse IEIs, offering crucial insights for patient management.
Area of Science:
- Clinical Immunology
- Diagnostic Pathology
- Medical Laboratory Science
Background:
- Inborn errors of immunity (IEIs) are a heterogeneous group of genetic disorders affecting the immune system.
- Accurate and timely diagnosis is crucial for effective management and improving patient outcomes.
- Flow cytometry (FCM) offers a powerful platform for evaluating immune cell populations and functions.
Purpose of the Study:
- To retrospectively review the utility of flow cytometry (FCM) in diagnosing inborn errors of immunity (IEIs).
- To present practical, FCM-based diagnostic approaches tailored to various clinical scenarios.
- To share experience from a single center in Algeria, highlighting its applicability in diverse settings.
Main Methods:
- Retrospective review of pediatric and adult patients with suspected immunodeficiency.
- Application of FCM for lymphocyte subset analysis, protein expression, and functional assays.
- Analysis of diagnostic yield for 70 different IEIs across 9 categories.
Main Results:
- FCM was utilized in the diagnosis of 670 patients over a nearly seven-year period.
- A total of 514 patients (76.7%) received diagnoses or supportive evidence for IEIs via FCM.
- FCM provided direct diagnoses for conditions like SCID and MHC class II deficiency, and suggestive evidence for others, guiding genetic testing.
Conclusions:
- Flow cytometry is a highly valuable and cost-effective method for diagnosing most IEIs.
- FCM is particularly relevant in low-income countries with limited access to genetic testing.
- FCM analysis provides direct diagnostic insights, suggests underlying genetic defects, and aids in gene prioritization for IEIs.

